182 related articles for article (PubMed ID: 2746481)
1. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
Green AR; Guillory JK
J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
[TBL] [Abstract][Full Text] [Related]
2. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
[TBL] [Abstract][Full Text] [Related]
3. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
Green AR; Miller ES; Guillory JK
J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
[No Abstract] [Full Text] [Related]
5. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
[TBL] [Abstract][Full Text] [Related]
6. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
Chen JY; Tsai WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
[TBL] [Abstract][Full Text] [Related]
7. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
Frank SG; Kavaliunas DR
J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
[TBL] [Abstract][Full Text] [Related]
9. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
Yoshida A; Yamamoto M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
[No Abstract] [Full Text] [Related]
10. Cyclodextrin complexation of barbiturates in aqueous solution.
Han SM; Purdie N
Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
[No Abstract] [Full Text] [Related]
11. Formation, characterization and pH dependence of rifampicin: heptakis(2,6-di-O-methyl)-β-cyclodextrin complexes.
Angiolini L; Agnes M; Cohen B; Yannakopoulou K; Douhal A
Int J Pharm; 2017 Oct; 531(2):668-675. PubMed ID: 28596140
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of an anthrapyrazole antitumour agent, DuP 937, on complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin in aqueous solution.
Raghavan K; Nemeth G; Gray D; Hussain MA
J Pharm Biomed Anal; 1994 Oct; 12(10):1259-64. PubMed ID: 7841220
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the methods for the determination of the stability constant of cyclodextrin-chlorambucil inclusion complexes.
Loukas YL
J Pharm Biomed Anal; 1997 Oct; 16(2):275-80. PubMed ID: 9408844
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
[TBL] [Abstract][Full Text] [Related]
15. Study of products containing mebendazole and beta-cyclodextrin.
Kata M; Papp L
Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
[No Abstract] [Full Text] [Related]
16. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
[No Abstract] [Full Text] [Related]
17. Colorimetric determination of beta-cyclodextrin: two assay modifications based on molecular complexation of phenolphtalein.
Mäkelä M; Korpela T; Laakso S
J Biochem Biophys Methods; 1987 Apr; 14(2):85-92. PubMed ID: 3693795
[TBL] [Abstract][Full Text] [Related]
18. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
Hirayama F; Kurihara M; Uekama K
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
[No Abstract] [Full Text] [Related]
19. Determination of association constants of beta-cyclodextrin and beta-cyclodextrin-bearing polymers with drugs by high-performance liquid chromatography.
Sébille B; Thuaud N; Piquion J; Behar N
J Chromatogr; 1987 Nov; 409():61-9. PubMed ID: 2826514
[TBL] [Abstract][Full Text] [Related]
20. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
